Delivery Order SPE2DR25D1100-SPE2DR26FCL9B
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Memantine HCL 2 mg/mL solution in 360 mL quantities, with a contract ceiling value of $1,360.68. This competitively awarded, firm fixed price delivery order is scheduled for completion by July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $6,884.33 to AmerisourceBergen Drug Corp for the supply of Memantine HCl 2 mg/mL solution in 360 mL quantities. The contract employs firm fixed price pricing with no set-aside designation, indicating competitive award, and carries an ultimate completion date of July 31, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $1,317.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Memantine HCL 2 mg/mL solution in 360 mL quantities. The delivery order, which represents no set-aside contract, is scheduled for completion by October 24, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a $202,050 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 60 packages containing 10 mg memantine hydrochloride tablets. The prime contractor will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania in support of the Defense Logistics Agency's medical supply chain requirements. No subcontractors or set aside designations were identified. The delivery order was issued under an existing DLA...
- The Defense Logistics Agency awarded a $37,660 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561503611 Memantine Hydrochloride 10mg tablets, 60 count. The delivery order was issued under an existing Prime Vendor pharmaceutical contract vehicle to provide pharmaceutical products and services to DLA and DoD customers. Performance will take place in Conshohocken, Pennsylvania with all items to be delivered by July 17, 2023. As the DoD's primary...
- The Defense Logistics Agency Troop Support Medical awarded a $12,400 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 60 boxes containing 10 mg tablets of memantine hydrochloride. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 31, 2023 through August 1, 2023. This delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen to...
- The Defense Logistics Agency awarded a $1.55 million firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561597862 memantine hydrochloride 10 mg tablets (60 count). The prime contractor will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 26, 2023 in support of Department of Defense requirements. Amerisourcebergen will perform under this delivery order issued against their Prime Vendor Next contract vehicle, through which DLA...
- The Defense Logistics Agency awarded a $37,200 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 60 boxes of 10mg memantine hydrochloride tablets. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order is for delivery between June 27-28, 2023 to support the Defense Logistics Agency's pharmaceutical procurement and distribution programs. No subcontractors or set aside designations were specified. The award draws upon...
- The Defense Logistics Agency awarded a $29,940 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 60 boxes of 10mg Memantine Hydrochloride tablets. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order period of performance is July 13-14, 2023. The Defense Logistics Agency procures pharmaceuticals and other medical commodities in support of the U.S. Department of Defense's healthcare programs. No subcontractors or set aside...
- The Defense Logistics Agency awarded a $6,200 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 60 boxes of 10mg memantine hydrochloride tablets. The order is to be fulfilled from Amerisourcebergen's facility located in Conshohocken, Pennsylvania by July 17, 2023 to support the Defense Logistics Agency's medical supply needs. Amerisourcebergen will serve as the prime contractor on the order, which was issued under the Defense Logistics Agency's...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCL9BDelivery Order
The Defense Logistics Agency awarded a $1,803.66 delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Memantine HCL 2 mg/mL solution in a 360 mL unit. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion deadline of November 3, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Memantine is a neurological medication commonly used in the treatment of moderate to severe Alzheimer's disease, reflecting the Defense Logistics Agency's ongoing procurement of specialized pharmaceutical products to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime vendor under this comprehensive global pharmaceutical support vehicle, AmerisourceBergen supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The company's federal contract history demonstrates consistent capability in fulfilling competitive federal medical procurement requirements through open competition, positioning it as a critical pharmaceutical distributor for the Department of Defense healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 10/31/25 |